A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAM / cancer-associated myositis

[Related PubMed/MEDLINE]
Total Number of Papers: 17
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAM  (>> Co-occurring Abbreviation)
Long Form:   cancer-associated myositis
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. AST, CRP, DM, IIMs, MG, MYOACT, PM
2018 The diagnostic work-up of cancer-associated myositis. ---
2018 Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis. LOH, TIF1
2017 Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study. HR, IIMs, MSAs, SIR
2017 Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. DM, IIM
2016 A case of non-specific interstitial pneumonia with recurrent gastric carcinoma and anti-Jo-1 antibody positive myositis. NSIP
2016 Anti-TIF1-gamma antibody and cancer-associated myositis: A clinicohistopathologic study. dC5b-9, DM, IIMs, NAM, VFs
2016 Cancer-associated myositis associated with oesophageal adenocarcinoma arising in Barrett's oesophagus without serum myogenic enzymes elevation: an example suggesting the importance of MRI. ---
2016 Clinical characteristics of patients with anti-TIF1-gamma antibodies. DM, TIF1-gamma
10  2016 Gene Expression Profile of Inflammatory Myopathy with Malignancy is Similar to that of Dermatomyositis rather than Polymyositis. DM, IHC, IMs, PM
11  2015 Peripheral T-cell lymphoma with hypercalcemic crisis as a primary symptom accompanied by polymyositis: A case report and review of the literature. ---
12  2014 Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validation. anti-TIF1-gamma, AUC, IP, NPV, PPV, ROC
13  2014 The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies. CRP, DM, MYOACT, PM
14  2012 Anti-TIF1gamma antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. DM, TIF1gamma
15  2010 Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. CI, DM, ORs, PM
16  2009 Defining cancer risk in dermatomyositis. Part I. DM, IBM, IIMs
17  2007 The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. DM, PM